(Alliance News) - AstraZeneca PLC on Friday said it has received positive data from a trial evaluating Imfinzi as a treatment for patients with high-risk non-muscle-invasive bladder cancer.

CAMBRIDGE, England--(BUSINESS WIRE)--AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint ...

It is working with other partners in the East of England to create a regional version of this database. We need this to happen at a UK-wide level. The UK is fortunate in that it has a single ...

Kadans already has lab space in Cambridge but will be adding to Manchester’s ecosystem with more than 200,000 sq ft of new lab space. Sheppard notes that Manchester is “not perfect”.

A few weeks later, Donelan was invited to visit AstraZeneca’s research and development site in Cambridge, the heartland of Britain’s life sciences sector, where she was treated to a glitzy ...

CAMBRIDGE — They had planned to spend retirement there. Then late last year, amid grave concerns about newly discovered structural issues in the building’s concrete, residents of the 66-unit ...

The Cambridge Fire Department said they received several 911 calls about the fire, which occurred at a large multi-family apartment building on Kirkland Street, just before midnight on Saturday.

AstraZeneca is expanding in Cambridge as it plans to grow Mass. presence AstraZeneca plans to give up its Waltham site after its new Cambridge facility is completed. expand.

Local News Structural issues cause evacuation of Cambridge condo building for at least a year A major infrastructure repair project will commence to shore up the building before the end of the year.

CAMBRIDGE — For many years, the hulking Riverview condo building has been a sought-after place to live in Cambridge, its 66 units of high-end housing offering residents an enviable perch ...

AstraZeneca’s £450m UK investment under review in state aid stand-off Pharma giant pauses plans for Liverpool factory as it ‘reviews incentives’ Save ...

The National Institute for Health and Care Excellence (NICE) has published a final draft guidance recommending Wainzua (eplontersen) for treatment of hereditary transthyretin-related amyloidosis (ATTR ...